R01CA76232/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2003	2
2007	1
2025	0

Page 1

The replication-competent oncolytic herpes simplex mutant virus NV1066 is effective in the treatment of esophageal cancer.

Stiles BM, Bhargava A, Adusumilli PS, Stanziale SF, Kim TH, Rusch VW, Fong Y. Stiles BM, et al. Surgery. 2003 Aug;134(2):357-64. doi: 10.1067/msy.2003.244. Surgery. 2003. PMID: 12947341

Neoadjuvant treatment of hepatic malignancy: an oncolytic herpes simplex virus expressing IL-12 effectively treats the parent tumor and protects against recurrence-after resection.

Jarnagin WR, Zager JS, Klimstra D, Delman KA, Malhotra S, Ebright M, Little S, DeRubertis B, Stanziale SF, Hezel M, Federoff H, Fong Y. Jarnagin WR, et al. Cancer Gene Ther. 2003 Mar;10(3):215-23. doi: 10.1038/sj.cgt.7700558. Cancer Gene Ther. 2003. PMID: 12637943

Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents.

Parks R, Gonen M, Kemeny N, Jarnagin W, D'Angelica M, DeMatteo R, Garden OJ, Blumgart LH, Fong Y. Parks R, et al. J Am Coll Surg. 2007 May;204(5):753-61; discussion 761-3. doi: 10.1016/j.jamcollsurg.2006.12.036. Epub 2007 Feb 23. J Am Coll Surg. 2007. PMID: 17481478

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year